首页|期刊导航|中国实验方剂学杂志|中医药调控BDNF/TrkB信号通路治疗缺血性脑卒中的研究进展

中医药调控BDNF/TrkB信号通路治疗缺血性脑卒中的研究进展OA

Traditional Chinese Medicine Treats Ischemic Stroke by Regulating BDNF/TrkB Signaling Pathway:A Review

中文摘要英文摘要

缺血性脑卒中(IS),是由于脑部血供不足引起脑组织坏死、神经功能缺损的急性脑血管疾病,表现为运动、语言、感觉、认知等功能受损.病机涉及炎症反应、兴奋性氨基酸毒性、线粒体功能异常等,具有高发病、高病死、高致残和高复发率的特点,属于我国第一致死病因.目前西医治疗主要为血管再通,包括溶栓和机械取栓.但由于血管内治疗可能出现脑出血和水肿,且具有狭窄的时间窗及较多的禁忌证,仅少数患者能从中获益,极大地限制了其临床应用.IS属于祖国医学"中风""偏枯""大厥"等范畴,主因风、火、痰、瘀损伤机体,致阴阳失调、气血逆乱,上犯清窍而发病;常治以平肝息风、化痰通络、活血祛瘀之法.中医药因其多途径、多靶点、不良反应低等特点,在改善患者预后及降低疾病复发率等方面具有良好的效果,值得进一步推广研究.脑源性神经营养因子(BDNF)在促进神经生成、增加突触可塑性等过程中发挥重要作用.在IS的疾病过程中,BDNF通过与酪氨酸激酶受体B(TrkB)结合,启动一系列细胞内信号级联反应,发挥神经保护作用.大量研究发现,中医药可以调控BDNF/TrkB信号通路,从调节突触可塑性,促进神经修复等方面治疗IS.笔者通过对近年来国内外文献进行梳理,将中药单体、单味中药及中药复方调控BDNF/TrkB信号通路治疗IS的机制进行总结归纳,以期为中医药治疗IS提供一定的理论依据及治疗参考.

Ischemic stroke(IS)is an acute cerebrovascular disease caused by insufficient blood supply to the brain,resulting in brain tissue necrosis and neurological dysfunction.It is characterized by impaired motor,language,sensory,cognitive,and other functions.The pathogenesis involves inflammatory responses,excitotoxicity of excitatory amino acids,and mitochondrial dysfunction.IS with a high incidence,high mortality,high disability,and a high recurrence rate is the leading cause of death in China.At present,Western medical therapies mainly focus on vascular recanalization,including thrombolysis and mechanical thrombectomy.However,due to the possibility of cerebral hemorrhage and edema,narrow time windows,and contraindications associated with intravascular therapy,only a few patients can benefit from these therapies,which greatly limit their clinical application.IS belongs to the categories such as stroke,hem iplegia,and major syncope in traditional Chinese medicine(TCM).It is mainly caused caused by wind,fire,phlegm,and stasis,which lead to imbalance of Yin and Yang,disorder of Qi and blood,and invasion of clear orifices.The common treatment methods include calming the liver and dispelling wind,resolving phlegm and unblocking meridians,and activating blood and resolving stasis.TCM acting on multiple pathways and targets with low toxicity and side effects has definite effects in improving the prognosis and reducing the recurrence rate,being worthy of promotion and research.Brain-derived neurotrophic factor(BDNF)plays a key role in promoting neurogenesis and increasing synaptic plasticity.During the progression of IS,BDNF binds to tyrosine kinase receptor B(TrkB)to initiate intracellular signaling cascades,thus exerting neuroprotective effects.Studies have shown that TCM can regulate the BDNF/TrkB signaling pathway,treating IS by regulating synaptic plasticity and promoting neural repair.This paper summarizes and generalizes the mechanisms of active components,single herbs,and compound prescriptions of TCM in regulating the BDNF/TrkB signaling pathway in the treatment of IS through the review of domestic and foreign literature in recent years,aiming to provide a theoretical basis and treatment reference for the treatment of IS with TCM.

王庆阁;刘飞祥;张运克

河南中医药大学第一附属医院,郑州 450000||河南中医药大学第一临床医学院,郑州 450000||河南省中医院/河南中医药大学第二附属医院,郑州 450000河南中医药大学第一附属医院,郑州 450000河南中医药大学第一附属医院,郑州 450000

医药卫生

缺血性脑卒中脑源性神经营养因子/酪氨酸激酶受体B(BDNF/TrkB)信号通路中医药机制研究进展

ischemic strokebrain-derived neurotrophic factor/tyrosine kinase receptor B(BDNF/TrkB)signaling pathwaytraditional Chinese medicinemechanismresearch progress

《中国实验方剂学杂志》 2026 (5)

312-321,10

国家自然科学基金项目(81974564,82104730)中原英才计划——科技创新领军人才项目(224200510027)河南省"双一流"创建学科中医学科学研究专项(HSRP-DFCTCM-2023-1-04)河南省中医药科学研究专项(2023ZY1030)

10.13422/j.cnki.syfjx.20250923

评论